103 related articles for article (PubMed ID: 9424810)
1. [The economic aspects of vaccination against hepatitis B].
Zhiburt EB
Voen Med Zh; 1997 Aug; 318(8):22-4. PubMed ID: 9424810
[No Abstract] [Full Text] [Related]
2. Why do we need a newer generation of recombinant vaccines against hepatitis B?
Chalasani N; Gitlin N
Am J Gastroenterol; 1997 Dec; 92(12):2314-5. PubMed ID: 9399785
[No Abstract] [Full Text] [Related]
3. Vaccination against hepatitis B in patients on chronic hemodialysis.
Kovacic V; Sain M; Vukman V
Saudi Med J; 2003 Mar; 24(3):311. PubMed ID: 12704514
[No Abstract] [Full Text] [Related]
4. DNA-based immunization against hepatitis B virus.
Davis HL; Brazolot Millan CL
Springer Semin Immunopathol; 1997; 19(2):195-209. PubMed ID: 9406346
[No Abstract] [Full Text] [Related]
5. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
[No Abstract] [Full Text] [Related]
6. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
7. Plasma-derived and recombinant hepatitis B vaccines.
John TJ
Indian Pediatr; 1997 Aug; 34(8):745-6. PubMed ID: 9492408
[No Abstract] [Full Text] [Related]
8. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccination in persons with isolated hepatitis B core antibodies.
Liesnard CA
Clin Infect Dis; 1999 Apr; 28(4):932-3. PubMed ID: 10825079
[No Abstract] [Full Text] [Related]
10. [Persistence of immunity after hepatitis B vaccination].
Madaliński K
Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccination: time for a booster?
Shopper T
LDA J; 1992; 51(3):5-6. PubMed ID: 9518764
[No Abstract] [Full Text] [Related]
12. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
Marinho RT; Ramalho F; Velosa J
Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
[No Abstract] [Full Text] [Related]
13. [The causes for hyporeactiveness of vaccination against hepatitis B and the strategies to resolve the situations].
Cheng SC; Lo CH
Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):108-10. PubMed ID: 8354106
[No Abstract] [Full Text] [Related]
14. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
15. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
16. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against hepatitis B: the Heptavax-B and Recombivax-HB vaccines.
Diaz-Arnold AM; Leary JM
Dentistry; 1989 Oct; 9(3):21-4. PubMed ID: 2534802
[No Abstract] [Full Text] [Related]
18. An economic evaluation of universal vaccination against hepatitis B virus.
Fenn P; Gray A; McGuire A
J Infect; 1996 May; 32(3):197-204. PubMed ID: 8793708
[TBL] [Abstract][Full Text] [Related]
19. [Long-term efficacy of vaccination against hepatitis B in newborns: 13 years' follow-up].
Wu W; Sun C; Jiang M; Xu Y; Zhang GH; Liu CB; Cao HL; Lin XM; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):239-41. PubMed ID: 11986695
[TBL] [Abstract][Full Text] [Related]
20. [Oral vaccines--a future prospect! Hepatitis vaccination in the vegetable market?].
Stiefelhagen P
MMW Fortschr Med; 2003 Nov; 145(47):10. PubMed ID: 14725025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
